Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Walgreens Boots Alliance, Inc.

Bristol-Myers vs. Walgreens: A Decade of Profit Battles

__timestampBristol-Myers Squibb CompanyWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20141194700000021569000000
Thursday, January 1, 20151265100000026753000000
Friday, January 1, 20161448100000029874000000
Sunday, January 1, 20171471000000029162000000
Monday, January 1, 20181601400000030792000000
Tuesday, January 1, 20191806700000028159000000
Wednesday, January 1, 20203074500000026077000000
Friday, January 1, 20213644500000028067000000
Saturday, January 1, 20223602200000028266000000
Sunday, January 1, 20233431300000027072000000
Monday, January 1, 20243635100000026524000000
Loading chart...

Unveiling the hidden dimensions of data

A Tale of Two Giants: Bristol-Myers Squibb vs. Walgreens Boots Alliance

In the ever-evolving landscape of the pharmaceutical and retail sectors, Bristol-Myers Squibb Company and Walgreens Boots Alliance, Inc. stand as titans. From 2014 to 2023, these companies have showcased their prowess in generating gross profit. Walgreens Boots Alliance consistently led the race until 2019, with gross profits peaking at approximately 3.08 billion in 2018. However, the tide turned in 2020 when Bristol-Myers Squibb surged ahead, achieving a remarkable 3.64 billion in 2021, marking a 20% increase from the previous year. This shift highlights Bristol-Myers Squibb's strategic advancements and market adaptability. As we look to the future, the data for 2024 remains incomplete, leaving room for speculation and anticipation. This dynamic competition underscores the importance of innovation and strategic foresight in maintaining industry leadership.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025